81/100B547.03
USD
4.03
(0.74%)
Pre Open·549.72USD+2.69(+0.49%)
Last updated: · Delayed 15 min
Vertex Pharmaceuticals net income 1990–2026What is an income statement? The income statement shows a company's revenue, costs and profit over a quarter or a year, from sales at the top to net income at the bottom.
Vertex Pharmaceuticals earned 653.60M USD in Q3 FY2026, the three months to 30 September 2026, down 39.6% on the same quarter a year before. Vertex Pharmaceuticals's net income over the last twelve months was 3.98B USD, up 8.2% on the twelve months before. In fiscal year 2025 it earned 3.95B USD, against a loss of 535.60M USD on the year before.
Last updated 9 Nov 2026 · Next report 11 Feb 2027
Net income
Net income Net margin
Growth
| Fiscal year | Period ending | Net income | Growth | Net margin | Revenue |
|---|---|---|---|---|---|
| TTM | 30 Sept 2026 | 3.98B | +8.18% | 30.61% | 12.99B |
| FY2025 | 31 Dec 2025 | 3.95B | — | 32.74% | 12.07B |
| FY2024 | 31 Dec 2024 | -535.60M | -114.80% | -4.86% | 11.02B |
| FY2023 | 31 Dec 2023 | 3.62B | +8.96% | 36.68% | 9.87B |
| FY2022 | 31 Dec 2022 | 3.32B | +41.84% | 37.20% | 8.93B |
| FY2021 | 31 Dec 2021 | 2.34B | -13.63% | 30.92% | 7.57B |
| FY2020 | 31 Dec 2020 | 2.71B | +130.43% | 43.70% | 6.21B |
| FY2019 | 31 Dec 2019 | 1.18B | -43.88% | 28.27% | 4.16B |
| FY2018 | 31 Dec 2018 | 2.10B | +695.83% | 68.80% | 3.05B |
| FY2017 | 31 Dec 2017 | 263.48M | — | 10.59% | 2.49B |
| FY2016 | 31 Dec 2016 | -112.05M | — | -6.58% | 1.70B |
| FY2015 | 31 Dec 2015 | -558.12M | — | -54.06% | 1.03B |
| FY2014 | 31 Dec 2014 | -738.56M | — | -127.25% | 580.42M |
| FY2013 | 31 Dec 2013 | -445.03M | — | -36.72% | 1.21B |
| FY2012 | 31 Dec 2012 | -107.03M | -461.91% | -7.01% | 1.53B |
| FY2011 | 31 Dec 2011 | 29.57M | — | 2.10% | 1.41B |
| FY2010 | 31 Dec 2010 | -754.63M | — | -526.35% | 143.37M |
| FY2009 | 31 Dec 2009 | -641.58M | — | -628.70% | 102.05M |
| FY2008 | 31 Dec 2008 | -459.85M | — | -262.02% | 175.50M |
| FY2007 | 31 Dec 2007 | -391.28M | — | -196.61% | 199.01M |
| FY2006 | 31 Dec 2006 | -206.89M | — | -95.63% | 216.36M |
| FY2005 | 31 Dec 2005 | -203.42M | — | -126.43% | 160.89M |
| FY2004 | 31 Dec 2004 | -166.25M | — | -161.85% | 102.72M |
| FY2003 | 31 Dec 2003 | -196.77M | — | -284.59% | 69.14M |
| FY2002 | 31 Dec 2002 | -108.62M | — | -67.43% | 161.09M |
| FY2001 | 31 Dec 2001 | -66.23M | — | -39.54% | 167.49M |
| FY2000 | 31 Dec 2000 | -39.66M | — | -50.76% | 78.13M |
| FY1999 | 31 Dec 1999 | -41.00M | — | -66.56% | 61.60M |
| FY1998 | 31 Dec 1998 | -33.10M | — | -74.55% | 44.40M |
| FY1997 | 31 Dec 1997 | -19.80M | — | -45.21% | 43.80M |
| FY1996 | 31 Dec 1996 | -40.00M | — | -300.75% | 13.30M |
| FY1995 | 31 Dec 1995 | -21.50M | — | -97.29% | 22.10M |
| FY1994 | 31 Dec 1994 | -17.60M | -980.00% | -89.80% | 19.60M |
| FY1993 | 31 Dec 1993 | 2.00M | — | 7.17% | 27.90M |
| FY1992 | 31 Dec 1992 | -8.50M | — | -223.68% | 3.80M |
| FY1991 | 31 Dec 1991 | -5.10M | — | -159.38% | 3.20M |
| FY1990 | 31 Dec 1990 | -4.30M | — | -186.96% | 2.30M |
| Quarter | Period ending | Net income | Growth on a year before | Net margin | Revenue |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 653.60M | -39.64% | 19.00% | 3.44B |
| Q2 FY2026 | 30 Jun 2026 | 1.10B | +6.48% | 32.99% | 3.33B |
| Q1 FY2026 | 31 Mar 2026 | 1.03B | +59.59% | 34.53% | 2.99B |
| Q4 FY2025 | 31 Dec 2025 | 1.19B | +30.46% | 36.91% | 3.23B |
| Q3 FY2025 | 30 Sept 2025 | 1.08B | +3.59% | 35.20% | 3.08B |
| Q2 FY2025 | 30 Jun 2025 | 1.03B | — | 34.84% | 2.96B |
| Q1 FY2025 | 31 Mar 2025 | 646.30M | -41.22% | 23.33% | 2.77B |
| Q4 FY2024 | 31 Dec 2024 | 913.00M | -5.76% | 31.35% | 2.91B |
| Q3 FY2024 | 30 Sept 2024 | 1.05B | +0.98% | 37.71% | 2.77B |
| Q2 FY2024 | 30 Jun 2024 | -3.59B | -492.44% | -135.83% | 2.65B |
| Q1 FY2024 | 31 Mar 2024 | 1.10B | +57.13% | 40.92% | 2.69B |
| Q4 FY2023 | 31 Dec 2023 | 968.80M | +18.31% | 38.48% | 2.52B |
| Q3 FY2023 | 30 Sept 2023 | 1.04B | +11.26% | 41.69% | 2.48B |
| Q2 FY2023 | 30 Jun 2023 | 915.70M | +12.98% | 36.73% | 2.49B |
| Q1 FY2023 | 31 Mar 2023 | 699.80M | -8.17% | 29.47% | 2.37B |
| Q4 FY2022 | 31 Dec 2022 | 818.90M | +6.34% | 35.56% | 2.30B |
| Q3 FY2022 | 30 Sept 2022 | 930.50M | +9.22% | 39.86% | 2.33B |
| Q2 FY2022 | 30 Jun 2022 | 810.50M | +1,111.08% | 36.90% | 2.20B |
| Q1 FY2022 | 31 Mar 2022 | 762.10M | +16.68% | 36.33% | 2.10B |
| Q4 FY2021 | 31 Dec 2021 | 770.10M | +27.46% | 37.16% | 2.07B |
| Q3 FY2021 | 30 Sept 2021 | 851.93M | +27.64% | 42.94% | 1.98B |
| Q2 FY2021 | 30 Jun 2021 | 66.92M | -92.01% | 3.73% | 1.79B |
| Q1 FY2021 | 31 Mar 2021 | 653.14M | +8.36% | 37.88% | 1.72B |
| Q4 FY2020 | 31 Dec 2020 | 604.19M | +3.59% | 37.12% | 1.63B |
| Q3 FY2020 | 30 Sept 2020 | 667.43M | +1,060.39% | 43.39% | 1.54B |
| Q2 FY2020 | 30 Jun 2020 | 837.27M | +213.08% | 54.92% | 1.52B |
| Q1 FY2020 | 31 Mar 2020 | 602.75M | +124.38% | 39.78% | 1.52B |
| Q4 FY2019 | 31 Dec 2019 | 583.23M | -62.38% | 41.27% | 1.41B |
| Q3 FY2019 | 30 Sept 2019 | 57.52M | -55.32% | 6.06% | 949.83M |
| Q2 FY2019 | 30 Jun 2019 | 267.43M | +28.97% | 28.41% | 941.29M |
| Q1 FY2019 | 31 Mar 2019 | 268.63M | +27.76% | 31.29% | 858.44M |
| Q4 FY2018 | 31 Dec 2018 | 1.55B | +1,439.99% | 178.20% | 870.11M |
| Q3 FY2018 | 30 Sept 2018 | 128.75M | — | 16.41% | 784.54M |
| Q2 FY2018 | 30 Jun 2018 | 207.36M | +1,052.26% | 27.57% | 752.16M |
| Q1 FY2018 | 31 Mar 2018 | 210.26M | -15.13% | 32.81% | 640.80M |
| Q4 FY2017 | 31 Dec 2017 | 100.68M | +205.61% | 15.45% | 651.63M |
| Q3 FY2017 | 30 Sept 2017 | -102.95M | — | -17.81% | 578.17M |
| Q2 FY2017 | 30 Jun 2017 | 18.00M | — | 3.31% | 544.14M |
| Q1 FY2017 | 31 Mar 2017 | 247.76M | — | 34.66% | 714.72M |
| Q4 FY2016 | 31 Dec 2016 | 32.95M | — | 7.18% | 458.71M |
| Q3 FY2016 | 30 Sept 2016 | -41.84M | — | -10.11% | 413.78M |
| Q2 FY2016 | 30 Jun 2016 | -64.53M | — | -14.95% | 431.61M |
| Q1 FY2016 | 31 Mar 2016 | -41.63M | — | -10.46% | 398.08M |
| Q4 FY2015 | 31 Dec 2015 | -75.51M | — | -18.07% | 417.94M |
| Q3 FY2015 | 30 Sept 2015 | -95.15M | — | -30.71% | 309.82M |
| Q2 FY2015 | 30 Jun 2015 | -188.85M | — | -113.71% | 166.08M |
| Q1 FY2015 | 31 Mar 2015 | -198.61M | — | -143.39% | 138.51M |
| Q4 FY2014 | 31 Dec 2014 | -176.66M | -498.91% | -122.21% | 144.56M |
| Q3 FY2014 | 30 Sept 2014 | -170.06M | — | -95.01% | 178.99M |
| Q2 FY2014 | 30 Jun 2014 | -159.38M | — | -115.14% | 138.42M |
| Q1 FY2014 | 31 Mar 2014 | -232.46M | — | -196.25% | 118.45M |
| Q4 FY2013 | 31 Dec 2013 | 44.29M | — | 12.61% | 351.16M |
| Q3 FY2013 | 30 Sept 2013 | -124.13M | — | -55.99% | 221.70M |
| Q2 FY2013 | 30 Jun 2013 | -57.17M | — | -18.40% | 310.75M |
| Q1 FY2013 | 31 Mar 2013 | -308.02M | -436.30% | -93.80% | 328.37M |
| Q4 FY2012 | 31 Dec 2012 | -76.15M | -148.00% | -22.80% | 333.99M |
| Q3 FY2012 | 30 Sept 2012 | -57.54M | -126.02% | -17.13% | 336.01M |
| Q2 FY2012 | 30 Jun 2012 | -64.93M | — | -15.52% | 418.31M |
| Q1 FY2012 | 31 Mar 2012 | 91.59M | — | 20.88% | 438.74M |
| Q4 FY2011 | 31 Dec 2011 | 158.63M | — | 28.16% | 563.34M |
| Q3 FY2011 | 30 Sept 2011 | 221.11M | — | 33.54% | 659.20M |
| Q2 FY2011 | 30 Jun 2011 | -174.07M | — | -152.13% | 114.42M |
| Q1 FY2011 | 31 Mar 2011 | -176.10M | — | -239.06% | 73.66M |
| Q4 FY2010 | 31 Dec 2010 | -180.39M | — | -275.31% | 65.52M |
| Q3 FY2010 | 30 Sept 2010 | -208.96M | — | -878.16% | 23.80M |
| Q2 FY2010 | 30 Jun 2010 | -200.01M | — | -632.49% | 31.62M |
| Q1 FY2010 | 31 Mar 2010 | -165.27M | — | -736.86% | 22.43M |
| Q4 FY2009 | 31 Dec 2009 | -158.64M | — | -468.13% | 33.89M |
| Q3 FY2009 | 30 Sept 2009 | -149.57M | — | -599.29% | 24.96M |
| Q2 FY2009 | 30 Jun 2009 | -171.30M | — | -898.54% | 19.06M |
| Q1 FY2009 | 31 Mar 2009 | -162.67M | — | -678.39% | 23.98M |
| Q4 FY2008 | 31 Dec 2008 | -142.33M | — | -433.79% | 32.81M |
| Q3 FY2008 | 30 Sept 2008 | -130.04M | — | -411.41% | 31.61M |
| Q2 FY2008 | 30 Jun 2008 | -91.32M | — | -131.57% | 69.41M |
| Q1 FY2008 | 31 Mar 2008 | -96.15M | — | -230.72% | 41.68M |
| Q4 FY2007 | 31 Dec 2007 | -85.75M | — | -168.17% | 50.99M |
| Q3 FY2007 | 30 Sept 2007 | -107.03M | — | -260.97% | 41.01M |
| Q2 FY2007 | 30 Jun 2007 | -117.77M | — | -308.32% | 38.20M |
| Q1 FY2007 | 31 Mar 2007 | -80.73M | — | -117.32% | 68.81M |
| Q4 FY2006 | 31 Dec 2006 | -27.34M | — | -29.01% | 94.25M |
| Q3 FY2006 | 30 Sept 2006 | -51.80M | — | -97.21% | 53.29M |
| Q2 FY2006 | 30 Jun 2006 | -77.66M | — | -261.25% | 29.73M |
| Q1 FY2006 | 31 Mar 2006 | -50.09M | — | -128.14% | 39.09M |
| Q4 FY2005 | 31 Dec 2005 | -38.13M | — | -59.81% | 63.76M |
| Q3 FY2005 | 30 Sept 2005 | -79.58M | — | -219.79% | 36.21M |
| Q2 FY2005 | 30 Jun 2005 | -40.99M | — | -126.82% | 32.32M |
| Q1 FY2005 | 31 Mar 2005 | -44.72M | — | -156.33% | 28.61M |
| Q4 FY2004 | 31 Dec 2004 | -42.77M | — | -107.37% | 39.84M |
| Q3 FY2004 | 30 Sept 2004 | -38.77M | — | -144.52% | 26.83M |
| Q2 FY2004 | 30 Jun 2004 | -44.27M | — | -238.76% | 18.54M |
| Q1 FY2004 | 31 Mar 2004 | -40.44M | -296.20% | -230.90% | 17.51M |
| Q4 FY2003 | 31 Dec 2003 | -41.03M | — | -386.92% | 10.60M |
| Q3 FY2003 | 30 Sept 2003 | -86.42M | — | -470.91% | 18.35M |
| Q2 FY2003 | 30 Jun 2003 | -45.80M | — | -260.57% | 17.58M |
| Q1 FY2003 | 31 Mar 2003 | 20.61M | — | 91.16% | 22.61M |
| Q4 FY2002 | 31 Dec 2002 | -32.08M | — | -73.28% | 43.78M |
| Q3 FY2002 | 30 Sept 2002 | -33.45M | — | -97.60% | 34.28M |
| Q2 FY2002 | 30 Jun 2002 | -21.02M | — | -49.66% | 42.33M |
| Q1 FY2002 | 31 Mar 2002 | -22.07M | — | -54.23% | 40.70M |
| Q4 FY2001 | 31 Dec 2001 | -3.26M | — | -6.33% | 51.53M |
| Q3 FY2001 | 30 Sept 2001 | -46.98M | — | -116.37% | 40.37M |
| Q2 FY2001 | 30 Jun 2001 | -12.11M | -195.99% | -56.46% | 21.44M |
| Q1 FY2001 | 31 Mar 2001 | -8.87M | — | -46.54% | 19.06M |
| Q4 FY2000 | 31 Dec 2000 | -11.25M | -762.00% | -57.12% | 19.70M |
| Q3 FY2000 | 30 Sept 2000 | -24.86M | — | -179.27% | 13.87M |
| Q2 FY2000 | 30 Jun 2000 | 12.61M | — | 34.06% | 37.03M |
| Q1 FY2000 | 31 Mar 2000 | -16.16M | — | -214.79% | 7.52M |
| Q4 FY1999 | 31 Dec 1999 | 1.70M | — | 5.74% | 29.60M |
| Q3 FY1999 | 30 Sept 1999 | -14.30M | — | -148.96% | 9.60M |
| Q2 FY1999 | 30 Jun 1999 | -10.80M | — | -70.59% | 15.30M |
| Q1 FY1999 | 31 Mar 1999 | -17.60M | — | -440.00% | 4.00M |
| Q4 FY1998 | 31 Dec 1998 | -12.60M | — | -107.69% | 11.70M |
| Q3 FY1998 | 30 Sept 1998 | -2.30M | — | -12.50% | 18.40M |
| Q2 FY1998 | 30 Jun 1998 | -9.80M | — | -136.11% | 7.20M |
| Q1 FY1998 | 31 Mar 1998 | -8.40M | — | -262.50% | 3.20M |
| Q4 FY1997 | 31 Dec 1997 | -6.80M | — | -60.71% | 11.20M |
| Q3 FY1997 | 30 Sept 1997 | -5.90M | — | -43.70% | 13.50M |
| Q2 FY1997 | 30 Jun 1997 | -1.40M | — | -11.48% | 12.20M |
| Q1 FY1997 | 31 Mar 1997 | -5.80M | — | -84.06% | 6.90M |
| Q4 FY1996 | 31 Dec 1996 | -3.90M | — | -81.25% | 4.80M |
| Q3 FY1996 | 30 Sept 1996 | -6.30M | — | -217.24% | 2.90M |
| Q2 FY1996 | 30 Jun 1996 | -22.30M | — | -719.35% | 3.10M |
| Q1 FY1996 | 31 Mar 1996 | -7.50M | — | -300.00% | 2.50M |
| Q4 FY1995 | 31 Dec 1995 | -800.00K | — | -9.76% | 8.20M |
| Q3 FY1995 | 30 Sept 1995 | -6.90M | — | -300.00% | 2.30M |
| Q2 FY1995 | 30 Jun 1995 | -9.00M | — | -138.46% | 6.50M |
| Q1 FY1995 | 31 Mar 1995 | -4.70M | — | -92.16% | 5.10M |
| Q4 FY1994 | 31 Dec 1994 | -4.90M | -156.32% | -181.48% | 2.70M |
| Q3 FY1994 | 30 Sept 1994 | -3.90M | — | -60.00% | 6.50M |
| Q2 FY1994 | 30 Jun 1994 | -5.50M | — | -114.58% | 4.80M |
| Q1 FY1994 | 31 Mar 1994 | -3.20M | — | -57.14% | 5.60M |
| Q4 FY1993 | 31 Dec 1993 | 8.70M | — | 48.33% | 18.00M |
| Q3 FY1993 | 30 Sept 1993 | -2.70M | — | -61.36% | 4.40M |
| Q2 FY1993 | 30 Jun 1993 | -800.00K | — | -17.39% | 4.60M |
| Q1 FY1993 | 31 Mar 1993 | -3.30M | — | -366.67% | 900.00K |
| Q4 FY1992 | 31 Dec 1992 | -2.70M | — | -270.00% | 1.00M |
| Q3 FY1992 | 30 Sept 1992 | -2.20M | — | -220.00% | 1.00M |
| Q2 FY1992 | 30 Jun 1992 | -1.90M | — | -190.00% | 1.00M |
| Q1 FY1992 | 31 Mar 1992 | -1.60M | — | -177.78% | 900.00K |
| Q4 FY1991 | 31 Dec 1991 | -1.30M | — | -162.50% | 800.00K |
| Q3 FY1991 | 30 Sept 1991 | -1.20M | — | -150.00% | 800.00K |
| Q2 FY1991 | 30 Jun 1991 | -1.40M | — | -175.00% | 800.00K |
| Q1 FY1991 | 31 Mar 1991 | -1.20M | — | -150.00% | 800.00K |
| Q4 FY1990 | 31 Dec 1990 | -1.10M | — | -183.33% | 600.00K |
| Q3 FY1990 | 30 Sept 1990 | -1.10M | — | -183.33% | 600.00K |
| Q2 FY1990 | 30 Jun 1990 | -1.10M | — | -183.33% | 600.00K |
| Q1 FY1990 | 31 Mar 1990 | -1.00M | — | -200.00% | 500.00K |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Vertex Pharmaceuticals's profit
Source: Financial Modeling Prep